Feasibility Study of Multidimensional Rehabilitation in the Metaverse

Colorectal Neoplasms Clinical Trial

Official title:

Feasibility Study of Multidimensional Rehabilitation in the Metaverse

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06354595
• Other study ID #: XiamenU1
• Status: Recruiting
• Phase: N/A
• Start date: March 1, 2024
• Est. completion date: May 1, 2024

Study information

• Verified date: April 2024
• Source: Xiamen University
• Contact: Qu SHEN
• Phone: +865922189613
• Email: shenqumail[@]163.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators evaluated and optimized the Metaverse multi-dimensional rehabilitation platform based on the use of the Metaverse multi-dimensional rehabilitation platform by colorectal cancer survivors and their families, and finally launched the Metaverse multi-dimensional rehabilitation platform.

Description:

The investigatorse intend to invite colorectal cancer survivors and their families to use the metaverse multi-dimensional rehabilitation platform. Interviews with users, user experience optimization of the metaverse multi-dimensional rehabilitation platform, and then evaluation of the platform through system usability evaluation. Gain insight into the experience of colorectal cancer survivors using the metaverse multi-dimensional rehabilitation platform, and understand their opinions and suggestions to explore the usability of the metaverse multi-dimensional rehabilitation platform.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10
• Est. completion date: May 1, 2024
• Est. primary completion date: April 30, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Patients undergoing adjuvant therapy after radical colorectal cancer resection; Age over 18 years old, under 65 years old, non-pregnant; Volunteering to participate in the research of this topic; Mobile phones are available

Exclusion Criteria:

• Patients with multiple cancers; Have special dietary needs.

Related Conditions & MeSH terms

• Colorectal Neoplasms

Intervention

Device:
• Multidimensional Rehabilitation in the Metaverse
Using the multidimensional rehabilitation space in the metaverse, evaluate the platform after use.

Locations

Country	Name	City	State
China	Yuru Hu	Xiamen	Fujian

Sponsors (2)

Lead Sponsor	Collaborator
Qu Shen	The First Affiliated Hospital of Xiamen University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Post-Study System Usability Questionnaire (PSSUQ) Third Edition	The questionnaire includes three dimensions: usefulness, information quality, interface quality, and one overall evaluation item, totaling 20 items. Each item is rated on a scale from 'strongly disagree' to 'strongly agree' with scores ranging from 1 to 5. A higher score indicates higher user satisfaction.	4th week
Primary	System Usability Scale (SUS)	Used to evaluate user experience, employing the Likert 5-point scale method, consisting of 10 questions. Questions 1, 3, 5, 7, and 9 are positively worded, while questions 2, 4, 6, 8, and 10 are negatively worded. The validity of the scale is 0.85. The SUS is scored on a percentage scale. When the questionnaire score is above 70, the product is considered 'good,' and above 50 is considered 'okay.	4th week
Secondary	Semi-structured interview	Through interviews, conducting interviews with colorectal cancer patients on the theme of 'platform implementation effectiveness' to understand the evaluation of colorectal cancer patients on this mobile healthcare platform.	4th week